Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Or simply exposed online...
Yikes. Should I sell since you are actually positive today?
Translation:
It's going to be a Merry Christmas.
Claudia's scan shows no new metastases and some of the lymph nodes are halved in size.
There is agreement among doctors that Klaudia should continue with immune therapy.
Klaudia is so happy, grateful, relieved and tired.
Thank you for all the good thoughts and encouragement. we fight on.
That's great news, is this DCVAX through specials programme?
No large waiting list as there is no large global awareness of DCVAX. It will take time, and TLD release to get more interest before RA approvals. Thus, the realistic expectations of revenues prior to approvals is lower than most here have speculated.
Manipulation as usual. Nothing happens until News.
Not true. There definitely could be a yes by now, and I'm trying to be confident there has been a yes. However, until reviewed by Journal, embargo on PR's and release dates.
The title may just be anecdotal based on this long road NWBO has taken. It may also have a happy ending!
Years ago, I Believe. There was a heated debate on ihub whether or not this was actually DCVAX. I believe it is, just not by trade name.
The best would be news, then breakout...double-whammy.
The title says nothing specifically about DCVAX. Trial design and struggles, etc. I expect nothing.
ASM is not comparable. They had blinded data in a crappy journal. Easy to shoot holes in that. That effort failed because they were promising TLD and end of trial and delivered nothing. They said TLD three times publicly last year, to be disclosed prior to end of September 2020. Then went quiet. Again, probably smart to begin with, but 16 months later, that is why we are at .74.
Once again, this is a self-imposed quiet period. Not required by SEC, thus no rules to follow.
Stop with the quiet period. It is self-imposed, number one. ZERO SEC requirement on this one. Number two, while there may have been a need for one to start, this is going on 16 months. Unacceptable, IMO. They refer back to Oct 2020 PR, language that talks about "steps" and we have no idea where we are. They could simply say "all internal and external advisory reviews are complete and we are working to get a Journal acceptance, at which point we will coordinate release of TLD in lock-step." Or something that checks a few boxes but doesn't commit to timelines or offend the FDA. It's not that difficult. And, apparently many others see that as well, which is why we are trading at .74.
Seriously? Internal Source?
There are several posters here who claim to be able to read tea leaves better than others. That is what I was refuting. And, I said, the passage of time is the only indicator that we should be closer. No One knows how far or close we are. That has been my issue consistently. Steps, processes, SAB, Journal, outside analysts, etc....lots of confusion, but no clarity from company. Thus, no one other than the company knows where we are.
Anyone claiming they know that we are closer to TLD, other than the simple passage of time, is guessing. Period. The company has given zero updates on TLD/Journal other than restating the same language in 10Q's and unrelated PR's.
I think we get the usual fomo run up prior to Bosch speaking next Wednesday. Then a retrace again end of next week if nothing new, which is likely.
What is the plan and does it have an end? He couldn't possibly tell you either of those things which is my problem with them. TLD/Journal...great, when?
None of your points below refute the fact that there has been ZERO info on trial data since Oct 5th, 2020. That is what is killing us, period. I have disagreed all along with the notion there are hundreds of million shares shorted, etc. The mysterious, never-ending "steps" in this unblinding process are the problem. They should be more transparent, and could be. They could do this without offending RA's as some suggest. They could do this without empowering fudsters, who, by the way, have not stopped during this process. Any clarity on where we are would keep us closer to $2 than zero, IMO.
Shorting does not get any less dangerous until the company says something to make it so. The silence is what is killing us. There are some who believe we will never see TLD. And, honestly, you can't say they are wrong given the past 15 months of silence. Just tell us where we are, even if it will be another few months.
We don't need money yet. no new financing until TLD, IMO.
This trading is brutal. So much for new year fomo ahead of conferences. Tired of it.
Chart is broken. Too many day traders in this thing now. 50 million share day needed to clean them out. And, that won't come until TLD. And, that won't come until.....that's right, we have no idea.
Still thinking we close green with the way the reversal has been looking.
consolidation head-fake. Don't fall for it.
On literally no volume. MM manipulation again.
Crashing?
I'll be long gone by ASCO with no TLD.
Consolidation day so far. Does the afternoon bring buying or selling?
At least you are now honest that you have been a trader in this stock, not a true long. Even amidst all your earlier pumping, you sold into it. Now we know, thanks.
Not going to happen today, the bomb that is. Usual MM tactics. Nothing new here. We need a leak and a 10 million share day.
Still need volume to pop. Just over a million shares won't do it. Afternoon buying would get us to .90/.91....
I have a feeling if we had a 5+ million share day we would test $1. Momentum is shifting but still running into resistance.
We are down almost 50% in the past 6 months. 9% back up does little. Until there is confidence and clarity on if/when we get TLD, we will not move up.
told ya, afternoon take-down again. lather, rinse, repeat.
Something wrong if not first quarter. TLD is beyond due, covid or no covid.
Buying has dried up and we will likely start this year with the usual afternoon fade back to red...
I am hoping for first quarter TLD as well. The rest would take care of itself with positive data/article.
Seriously? A compassionate use, unapproved therapy vs. an FDA/UK/EMA approved brain cancer treatment? Night and day. Marketing an approved treatment is a lot different than trying to get people to believe in a "possible" positive outcome of an experimental therapy. Approved is a billion dollar revenue source. Specials is a cash-flow helper until approval. Period. Nothing matters now other than TLD.
The Specials will not likely bring in hundreds of millions in revenue. More realistically, 10's of millions. It helps with RA approvals as manufacturing is almost ready but it doesn't mean much more than that at this point.